Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Afr Health Sci ; 9(4): 212-7, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21503171

RESUMO

BACKGROUND: Currently, a major problem in the management of visceral leishmaniasis or kala-azar, especially in the Indian subcontinent, is the growing unresponsiveness to conventional antimonial therapy. Membrane bound pyrophophatase (PPases) do not exist in plasma membrane from mammals. Thus, H(+)-PPases from Leishmania plasma membrane might be potential target in rational chemotherapy of the disease caused by Leishmania parasites. OBJECTIVE: To characterize the activities of inorganic pyrophophatase (PPase) in the plasma membrane of Leishmania donovani promastigote and amastigote. METHODS: Culture method of promastigote and amastigote were developed. We assayed PPase activity in isolated plasma membrane of L. donovani. RESULTS: We characterized K(+)-PPase present in the plasma membrane of Leishmania donovani and investigated its possible role in the survival of promastigote and amastigote. PPase activity was stimulated by K(+) ions and sodium orthovanadate, inhibited by pyrophosphate analogs imidodiphosphate and alendronate, KF, DCCD, thiol reagent parachloromercuribenzenesulfonate (PCMBS), N-ethylmaliemide (NEM), phenylarsineoxide, ABC superfamily transport modulator verapamil and was also by F(1)F(o)-ATPase inhibitor quercetin. CONCLUSION: We conclude that there are significant differences within promastigote, amastigote and mammalian host in cytosolic pH homeostasis to merit the inclusion of PPase transporter as putative targets for rational drug design.


Assuntos
Membrana Celular/enzimologia , Pirofosfatase Inorgânica/metabolismo , Leishmania donovani/metabolismo , Animais , Antiprotozoários/farmacologia , Desenho de Fármacos , Resistência Microbiana a Medicamentos , Pirofosfatase Inorgânica/efeitos dos fármacos , Leishmaniose/tratamento farmacológico
2.
Archaea ; 1(6): 385-9, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16243777

RESUMO

A gene encoding for a putative Family I inorganic pyrophosphatase (PPase, EC 3.6.1.1) from the hyperthermophilic archaeon Pyrococcus horikoshii OT3 was cloned and the biochemical characteristics of the resulting recombinant protein were examined. The gene (Accession No. 1907) from P. horikoshii showed some identity with other Family I inorganic pyrophosphatases from archaea. The recombinant PPase from P. horikoshii (PhPPase) has a molecular mass of 24.5 kDa, determined by SDS-PAGE. This enzyme specifically catalyzed the hydrolysis of pyrophosphate and was sensitive to NaF. The optimum temperature and pH for PPase activity were 70 degrees C and 7.5, respectively. The half-life of heat inactivation was about 50 min at 105 degrees C. The heat stability of PhPPase was enhanced in the presence of Mg2+. A divalent cation was absolutely required for enzyme activity, Mg2+ being most effective; Zn2+, Co2+ and Mn2+ efficiently supported hydrolytic activity in a narrow range of concentrations (0.05-0.5 mM). The K(m) for pyrophosphate and Mg2+ were 113 and 303 microM, respectively; and maximum velocity, V(max), was estimated at 930 U mg(-1).


Assuntos
Pirofosfatase Inorgânica/química , Pirofosfatase Inorgânica/metabolismo , Pyrococcus horikoshii/enzimologia , Difosfatos/metabolismo , Escherichia coli/metabolismo , Concentração de Íons de Hidrogênio , Hidrólise , Pirofosfatase Inorgânica/efeitos dos fármacos , Pirofosfatase Inorgânica/genética , Peso Molecular , Proteínas Recombinantes/biossíntese , Fluoreto de Sódio/farmacologia , Especificidade por Substrato
3.
Biochim Biophys Acta ; 1656(2-3): 88-95, 2004 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-15178470

RESUMO

Vacuolar H(+)-translocating pyrophosphatase (H(+)-PPase; EC 3.6.1.1) catalyzes both the hydrolysis of PP(i) and the electrogenic translocation of proton from the cytosol to the lumen of the vacuole. Vacuolar H(+)-PPase, purified from etiolated hypocotyls of mung bean (Vigna radiata L.), is a homodimer with a molecular mass of 145 kDa. To investigate the relationship between structure and function of this H(+)-translocating enzyme, thermoinactivation analysis was employed. Thermoinactivation studies suggested that vacuolar H(+)-PPase consists of two distinct states upon heat treatment and exhibited different transition temperatures in the presence and absence of ligands (substrate and inhibitors). Substrate protection of H(+)-PPase stabilizes enzyme structure by increasing activation energy from 54.9 to 70.2 kJ/mol. We believe that the conformation of this enzyme was altered in the presence of substrate to protect against the thermoinactivation. In contrast, the modification of H(+)-PPase by inhibitor (fluorescein 5'-isothiocyanate; FITC) augmented the inactivation by heat treatment. The native, substrate-bound, and FITC-labeled vacuolar H(+)-PPases possess probably distinct conformation and show different modes of susceptibility to thermoinactivation. Our results also indicate that the structure of one subunit of this homodimer exerts long distance effect on the other, suggesting a specific subunit-subunit interaction in vacuolar H(+)-PPase. A working model was proposed to interpret the relationship of the structure and function of vacuolar H(+)-PPase.


Assuntos
Fabaceae/enzimologia , Temperatura Alta , Pirofosfatase Inorgânica/análise , Prótons , Vacúolos/enzimologia , Varredura Diferencial de Calorimetria , Dimerização , Inibidores Enzimáticos/farmacologia , Estabilidade Enzimática , Fluoresceína-5-Isotiocianato/farmacologia , Hidrólise , Hipocótilo/química , Pirofosfatase Inorgânica/química , Pirofosfatase Inorgânica/efeitos dos fármacos , Pirofosfatase Inorgânica/isolamento & purificação , Cinética , Modelos Teóricos , Peso Molecular , Conformação Proteica , Subunidades Proteicas/química , Relação Estrutura-Atividade , Especificidade por Substrato , Termodinâmica
4.
Biochim Biophys Acta ; 1656(2-3): 156-65, 2004 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-15178477

RESUMO

The membrane-bound proton-pumping inorganic pyrophosphatase from Rhodospirillum rubrum was heterologously expressed in Escherichia coli C43(DE3) cells and was inhibited by 4-bromophenacyl bromide (BPB), N,N'-dicyclohexylcarbodiimid (DCCD), diethyl pyrocarbonate (DEPC) and fluorescein 5'-isothiocyanate (FITC). In each case, the enzyme activity was rather well protected against inhibitory action by the substrate Mg(2)PPi. Site-directed mutagenesis was employed in attempts to identify target residues for these inhibitors. D217 and K469 appear to be the prime targets for DCCD and FITC, respectively, and may thus be involved in substrate binding. No major effect on enzyme activities was seen when any one of the four histidine residues present in the enzyme were substituted. Nevertheless, a mutant with all of the four charged histidine residues replaced retained only less than 10% of the hydrolysis and proton-pumping activities. Substitution of D217 with A or H yielded an enzyme with at least an order of magnitude lower hydrolysis activity. In contrast with the wild-type, these variants showed higher hydrolysis rates at lower concentrations of Mg(2+), possibly reflecting a change in substrate preference from Mg(2)PPi to MgPPi. BPB is a H(+)-pyrophosphatase inhibitor that apparently has not been used previously as an inhibitor of these enzymes.


Assuntos
Escherichia coli/enzimologia , Escherichia coli/metabolismo , Pirofosfatase Inorgânica/antagonistas & inibidores , Fosforilcolina/análogos & derivados , Prótons , Rhodospirillum rubrum/enzimologia , Acetofenonas/farmacologia , Western Blotting , Dicicloexilcarbodi-Imida/farmacologia , Inibidores Enzimáticos/farmacologia , Fluoresceína-5-Isotiocianato/farmacologia , Variação Genética , Histidina/química , Histidina/genética , Histidina/metabolismo , Hidrólise/efeitos dos fármacos , Pirofosfatase Inorgânica/efeitos dos fármacos , Pirofosfatase Inorgânica/genética , Pirofosfatase Inorgânica/metabolismo , Magnésio/metabolismo , Mutagênese Sítio-Dirigida , Mutação , Fosforilcolina/farmacologia , Rhodospirillum rubrum/genética , Especificidade por Substrato
5.
Histochem Cell Biol ; 121(5): 407-18, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15138840

RESUMO

Growth of Leishmania mexicana amazonensis promastigotes in different culture media resulted in structurally and chemically different acidocalcisomes. When grown in SDM-79 medium, the promastigotes showed large spherical acidocalcisomes of up to 1.2 microm diameter distributed throughout the cell. X-ray microanalysis and elemental mapping of the organelles showed large amounts of oxygen, phosphorus, sodium, potassium, magnesium, calcium, and zinc. Immunofluorescence microscopy using antisera raised against a peptide sequence of the vacuolar-type proton pyrophosphatase of Arabidopsis thaliana that is conserved in the Leishmania enzyme, indicated localization in acidocalcisomes. When cells were transferred to Warren's medium, the acidocalcisomes transformed from spherical into branched tubular organelles. The labeling pattern of the vacuolar proton-pyrophosphatase, considered as a marker for the organelle, changed accompanying the structural changes of the acidocalcisomes, and the enzyme showed an apparently lower proton-transporting activity when measured in digitonin-permeabilized promastigotes. X-ray microanalysis and elemental mapping of these structures revealed the additional presence of iron. Together, the results reveal that the morphology and composition of acidocalcisomes are greatly influenced by the culture conditions.


Assuntos
Vesículas Citoplasmáticas/ultraestrutura , Leishmania mexicana/crescimento & desenvolvimento , Laranja de Acridina/metabolismo , Animais , Cálcio/análise , Meios de Cultura/farmacologia , Vesículas Citoplasmáticas/efeitos dos fármacos , Vesículas Citoplasmáticas/enzimologia , Microanálise por Sonda Eletrônica , Imageamento Tridimensional , Pirofosfatase Inorgânica/análise , Pirofosfatase Inorgânica/efeitos dos fármacos , Ferro/análise , Ferro/metabolismo , Leishmania mexicana/citologia , Leishmania mexicana/efeitos dos fármacos , Fusão de Membrana/efeitos dos fármacos , Microscopia Eletrônica de Transmissão , Microscopia de Fluorescência , Microscopia Imunoeletrônica , Nigericina/farmacologia
6.
FEBS Lett ; 560(1-3): 158-66, 2004 Feb 27.
Artigo em Inglês | MEDLINE | ID: mdl-14988016

RESUMO

A single-copy gene IPP encoding a putative soluble inorganic pyrophosphatase (LmsPPase, EC 3.6.1.1) was identified in the genome of the parasite protozoan Leishmania major. The full-length coding sequence (ca. 0.8 kb) was obtained from genomic DNA by polymerase chain reaction (PCR) and cloned into an Escherichia coli expression vector, and was overexpressed for functional protein purification and characterization. The recombinant LmsPPase, purified to electrophoretic homogeneity by a two-step chromatography procedure, exhibited a predicted molecular mass of ca. 30 kDa. The enzyme has an absolute requirement for divalent cations, exhibits a pH optimum of 7.5-8.0 and does not hydrolyze polyphosphates or adenosine triphosphate (ATP). LmsPPase differs from previously studied soluble pyrophosphatases with respect to cation selectivity, Ca(2+) being far more effective than Mg(2+). Comparisons to known sPPases show a short N-terminal extension predicted to be a mitochondrial transit peptide, and changes in active-site residues and the neighboring region. Subcellular fractionation of L. major promastigotes suggests a mitochondrial localization. Molecular phylogenetic analysis indicates that LmsPPase is a highly divergent eukaryotic Family I sPPase, perhaps an ancestral class of eukaryotic sPPases functionally adapted to a calcium-rich, probably mitochondrial, environment.


Assuntos
Cálcio/farmacologia , Pirofosfatase Inorgânica/química , Pirofosfatase Inorgânica/metabolismo , Leishmania major/enzimologia , Sequência de Aminoácidos , Animais , Sequência Conservada , Escherichia coli/genética , Células Eucarióticas/enzimologia , Genoma de Protozoário , Concentração de Íons de Hidrogênio , Pirofosfatase Inorgânica/efeitos dos fármacos , Pirofosfatase Inorgânica/isolamento & purificação , Leishmania major/genética , Dados de Sequência Molecular , Peso Molecular , Filogenia , Proteínas Recombinantes/química , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Solubilidade , Especificidade por Substrato
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...